
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
MicroRNA‐506 promotes primary biliary cholangitis–like features in cholangiocytes and immune activation
Oihane Erice, Patricia Muñoz-Garrido, Javier Vaquero, et al.
Hepatology (2017) Vol. 67, Iss. 4, pp. 1420-1440
Open Access | Times Cited: 83
Oihane Erice, Patricia Muñoz-Garrido, Javier Vaquero, et al.
Hepatology (2017) Vol. 67, Iss. 4, pp. 1420-1440
Open Access | Times Cited: 83
Showing 1-25 of 83 citing articles:
Cholangiocyte pathobiology
Jesús M. Bañales, Robert C. Huebert, Tom H. Karlsen, et al.
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 16, Iss. 5, pp. 269-281
Open Access | Times Cited: 380
Jesús M. Bañales, Robert C. Huebert, Tom H. Karlsen, et al.
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 16, Iss. 5, pp. 269-281
Open Access | Times Cited: 380
Primary biliary cholangitis: pathogenesis and therapeutic opportunities
Aliya Gulamhusein, Gideon M. Hirschfield
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 17, Iss. 2, pp. 93-110
Closed Access | Times Cited: 239
Aliya Gulamhusein, Gideon M. Hirschfield
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 17, Iss. 2, pp. 93-110
Closed Access | Times Cited: 239
Primary biliary cholangitis
Ana Lleò, Giu-Qiang Wang, M. Eric Gershwin, et al.
The Lancet (2020) Vol. 396, Iss. 10266, pp. 1915-1926
Closed Access | Times Cited: 178
Ana Lleò, Giu-Qiang Wang, M. Eric Gershwin, et al.
The Lancet (2020) Vol. 396, Iss. 10266, pp. 1915-1926
Closed Access | Times Cited: 178
The Pathogenesis of Primary Biliary Cholangitis: A Comprehensive Review
Ana Lleò, Patrick S.C. Leung, Gideon M. Hirschfield, et al.
Seminars in Liver Disease (2019) Vol. 40, Iss. 01, pp. 034-048
Closed Access | Times Cited: 111
Ana Lleò, Patrick S.C. Leung, Gideon M. Hirschfield, et al.
Seminars in Liver Disease (2019) Vol. 40, Iss. 01, pp. 034-048
Closed Access | Times Cited: 111
The challenges of primary biliary cholangitis: What is new and what needs to be done
Benedetta Terziroli Beretta‐Piccoli, Giorgina Mieli‐Vergani, Diego Vergani, et al.
Journal of Autoimmunity (2019) Vol. 105, pp. 102328-102328
Open Access | Times Cited: 106
Benedetta Terziroli Beretta‐Piccoli, Giorgina Mieli‐Vergani, Diego Vergani, et al.
Journal of Autoimmunity (2019) Vol. 105, pp. 102328-102328
Open Access | Times Cited: 106
The pathogenic, therapeutic and diagnostic role of exosomal microRNA in the autoimmune diseases
Rasoul Mirzaei, Farhad Zamani, Marzieh Hajibaba, et al.
Journal of Neuroimmunology (2021) Vol. 358, pp. 577640-577640
Closed Access | Times Cited: 86
Rasoul Mirzaei, Farhad Zamani, Marzieh Hajibaba, et al.
Journal of Neuroimmunology (2021) Vol. 358, pp. 577640-577640
Closed Access | Times Cited: 86
Immunological abnormalities in patients with primary biliary cholangitis
Wentao Ma, Dekun Chen
Clinical Science (2019) Vol. 133, Iss. 6, pp. 741-760
Closed Access | Times Cited: 43
Wentao Ma, Dekun Chen
Clinical Science (2019) Vol. 133, Iss. 6, pp. 741-760
Closed Access | Times Cited: 43
Fibrotic Events in the Progression of Cholestatic Liver Disease
Hanghang Wu, Chaobo Chen, Siham Ziani, et al.
Cells (2021) Vol. 10, Iss. 5, pp. 1107-1107
Open Access | Times Cited: 39
Hanghang Wu, Chaobo Chen, Siham Ziani, et al.
Cells (2021) Vol. 10, Iss. 5, pp. 1107-1107
Open Access | Times Cited: 39
Primary biliary cholangitis: molecular pathogenesis perspectives and therapeutic potential of natural products
Yanling Zhao, Shizhang Wei, Lisheng Chen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14
Yanling Zhao, Shizhang Wei, Lisheng Chen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14
Reasons why women are more likely to develop primary biliary cholangitis
Ma Di, Jiaxuan Ma, Chun‐Mei Zhao, et al.
Heliyon (2024) Vol. 10, Iss. 4, pp. e25634-e25634
Open Access | Times Cited: 6
Ma Di, Jiaxuan Ma, Chun‐Mei Zhao, et al.
Heliyon (2024) Vol. 10, Iss. 4, pp. e25634-e25634
Open Access | Times Cited: 6
Sex-related factors in autoimmune liver diseases
Dorothee Schwinge, Christoph Schramm
Seminars in Immunopathology (2018) Vol. 41, Iss. 2, pp. 165-175
Closed Access | Times Cited: 44
Dorothee Schwinge, Christoph Schramm
Seminars in Immunopathology (2018) Vol. 41, Iss. 2, pp. 165-175
Closed Access | Times Cited: 44
Primary biliary cholangitis: A tale of epigenetically-induced secretory failure?
Pedro M. Rodrigues, María J. Perugorria, Álvaro Santos‐Laso, et al.
Journal of Hepatology (2018) Vol. 69, Iss. 6, pp. 1371-1383
Open Access | Times Cited: 42
Pedro M. Rodrigues, María J. Perugorria, Álvaro Santos‐Laso, et al.
Journal of Hepatology (2018) Vol. 69, Iss. 6, pp. 1371-1383
Open Access | Times Cited: 42
Exosomal microRNA in autoimmunity
Weijia Duan, Weici Zhang, Jidong Jia, et al.
Cellular and Molecular Immunology (2019) Vol. 16, Iss. 12, pp. 932-934
Open Access | Times Cited: 40
Weijia Duan, Weici Zhang, Jidong Jia, et al.
Cellular and Molecular Immunology (2019) Vol. 16, Iss. 12, pp. 932-934
Open Access | Times Cited: 40
Secretin/secretin receptor signaling mediates biliary damage and liver fibrosis in early‐stage primary biliary cholangitis
Lindsey Kennedy, Heather Francis, Pietro Invernizzi, et al.
The FASEB Journal (2019) Vol. 33, Iss. 9, pp. 10269-10279
Open Access | Times Cited: 38
Lindsey Kennedy, Heather Francis, Pietro Invernizzi, et al.
The FASEB Journal (2019) Vol. 33, Iss. 9, pp. 10269-10279
Open Access | Times Cited: 38
Immune system and cholangiocytes: A puzzling affair in primary biliary cholangitis
Vincenzo Ronca, Clara Mancuso, Chiara Milani, et al.
Journal of Leukocyte Biology (2020) Vol. 108, Iss. 2, pp. 659-671
Closed Access | Times Cited: 35
Vincenzo Ronca, Clara Mancuso, Chiara Milani, et al.
Journal of Leukocyte Biology (2020) Vol. 108, Iss. 2, pp. 659-671
Closed Access | Times Cited: 35
The Role of Epigenetics in Primary Biliary Cholangitis
Alessio Gerussi, Elvezia Maria Paraboschi, Claudio Cappadona, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4873-4873
Open Access | Times Cited: 19
Alessio Gerussi, Elvezia Maria Paraboschi, Claudio Cappadona, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4873-4873
Open Access | Times Cited: 19
The Dynamic Role of Endoplasmic Reticulum Stress in Chronic Liver Disease
Kaitlyn G. Jackson, Grayson W. Way, Jing Zeng, et al.
American Journal Of Pathology (2023) Vol. 193, Iss. 10, pp. 1389-1399
Open Access | Times Cited: 12
Kaitlyn G. Jackson, Grayson W. Way, Jing Zeng, et al.
American Journal Of Pathology (2023) Vol. 193, Iss. 10, pp. 1389-1399
Open Access | Times Cited: 12
Primary biliary cholangitis: pathogenic mechanisms
Jesús Prìeto, Jesús M. Bañales, Juan Francisco Medina Gallardo
Current Opinion in Gastroenterology (2020) Vol. 37, Iss. 2, pp. 91-98
Open Access | Times Cited: 31
Jesús Prìeto, Jesús M. Bañales, Juan Francisco Medina Gallardo
Current Opinion in Gastroenterology (2020) Vol. 37, Iss. 2, pp. 91-98
Open Access | Times Cited: 31
Single cell sequencing analysis identifies genetics-modulated ORMDL3+ cholangiocytes having higher metabolic effects on primary biliary cholangitis
Bingyu Xiang, Chunyu Deng, Fei Qiu, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 26
Bingyu Xiang, Chunyu Deng, Fei Qiu, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 26
Galectin-3 and prohibitin 1 are autoantigens in IgG4-related cholangitis without clear-cut protective effects against toxic bile acids
Remco Kersten, David C. Trampert, Lowiek M. Hubers, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 3
Remco Kersten, David C. Trampert, Lowiek M. Hubers, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 3
Current Treatment Regimens and Promising Molecular Therapies for Chronic Hepatobiliary Diseases
Marilena Durazzo, Arianna Ferro, Victor Navarro‐Tableros, et al.
Biomolecules (2025) Vol. 15, Iss. 1, pp. 121-121
Open Access
Marilena Durazzo, Arianna Ferro, Victor Navarro‐Tableros, et al.
Biomolecules (2025) Vol. 15, Iss. 1, pp. 121-121
Open Access
Epidemiology, Pathogenesis and Treatment Progress of Primary Biliary Cholangitis
兴丹 余
Advances in Clinical Medicine (2025) Vol. 15, Iss. 03, pp. 153-160
Closed Access
兴丹 余
Advances in Clinical Medicine (2025) Vol. 15, Iss. 03, pp. 153-160
Closed Access
An Integrated Pathogenetic Model of Primary Biliary Cholangitis
Elias Kouroumalis, Ioannis Tsomidis, Argyro Voumvouraki
Livers (2025) Vol. 5, Iss. 2, pp. 15-15
Open Access
Elias Kouroumalis, Ioannis Tsomidis, Argyro Voumvouraki
Livers (2025) Vol. 5, Iss. 2, pp. 15-15
Open Access
Clinical management of autoimmune liver diseases: juncture, opportunities, and challenges ahead
Yangfan Chen, Ruofei Chen, Haiyan Li, et al.
Immunologic Research (2025) Vol. 73, Iss. 1
Open Access
Yangfan Chen, Ruofei Chen, Haiyan Li, et al.
Immunologic Research (2025) Vol. 73, Iss. 1
Open Access
Role of Bile Acids and the Biliary HCO3− Umbrella in the Pathogenesis of Primary Biliary Cholangitis
Jorrit van Niekerk, Remco Kersten, Ulrich Beuers
Clinics in Liver Disease (2018) Vol. 22, Iss. 3, pp. 457-479
Closed Access | Times Cited: 28
Jorrit van Niekerk, Remco Kersten, Ulrich Beuers
Clinics in Liver Disease (2018) Vol. 22, Iss. 3, pp. 457-479
Closed Access | Times Cited: 28